HealthcareNSE · BSE

Thyrocare Technologies Limited

THYROCARE · ISIN INE594H01019

Share price

₹544▲ +1.58%

Market capitalisation

₹8659 Cr● Closed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹8659 Cr

Current price

₹544

+1.58% today

52W high

₹578

52W low

₹318

Stock P/E

53.18

P/B ratio

16.19

02 · Per share & returns

EPS (TTM)

₹10.23

Book value

₹33.60

ROE

28.75%

ROA

17.69%

Dividend yield

3.05%

Beta

0.47

03 · Financials (TTM)

By the numbers

Revenue

₹829 Cr

+19.70% YoY

EBITDA

₹243 Cr

Net profit

₹163 Cr

+116.30% YoY

Profit margin

19.67%

Operating margin

27.40%

Total debt

₹50.69 Cr

Total cash

₹190 Cr

Debt / equity

0.09x

Current ratio

3.39x

Payout ratio

91.38%

04 · Analyst view

Target price

₹600

Upside

+10.28%

Consensus

NONE

Analysts

05 · Shareholding pattern

Who owns THYROCARE?

Promoters
60.92%
Founders & promoter group
Institutions
21.41%
FII + DII
Public
17.67%
Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol: THYROCARE
Exchange: NSE · BSE
CIN: —
ISIN: INE594H01019
BSE code: 539871
Sector: Healthcare
Industry: Healthcare
Face value: ₹10
Listing date: 08 May 2016
Employees: 1,906
Headquarters: Navi Mumbai, India
Website: www.thyrocare.com

07 · About

What is Thyrocare Technologies Limited?

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

08 · Common questions

Frequently asked

What is the CIN of Thyrocare Technologies Limited?+

The Corporate Identity Number for Thyrocare Technologies Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Thyrocare Technologies Limited?+

Promoter holding in THYROCARE is approximately 60.92%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Thyrocare Technologies Limited?+

Thyrocare Technologies Limited (THYROCARE) has a market capitalisation of approximately ₹8659 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent